CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.
Wearable mobile health technology could help people with type 2 diabetes (T2D) to stick to exercise regimens that help them ...
First approved therapy to address hyperphagia in individuals with Prader-Willi syndromeManagement to host conference call and webcast today, ...
Zacks Investment Research on MSN14h
DXCM Stock Gains Following New Data on Upcoming G7 CGM SensorDexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback